prismasol b22gk4/0

Generic: magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride

Labeler: vantive us healthcare llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name prismasol b22gk4/0
Generic Name magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride
Labeler vantive us healthcare llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

anhydrous dextrose 20 g/L, lactic acid 5.4 g/L, magnesium chloride 3.05 g/L, potassium chloride .314 g/L, sodium bicarbonate 2.21 g/L, sodium chloride 7.07 g/L

Manufacturer
Vantive US Healthcare LLC

Identifiers & Regulatory

Product NDC 24571-111
Product ID 24571-111_37da3e2a-3a1a-1784-e063-6394a90a969f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021703
Listing Expiration 2026-12-31
Marketing Start 2006-10-25

Pharmacologic Class

Classes
acidifying activity [moa] calculi dissolution agent [epc] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24571111
Hyphenated Format 24571-111

Supplemental Identifiers

UNII
M4I0D6VV5M GR686LBA74 660YQ98I10 451W47IQ8X 5SL0G7R0OK 02F3473H9O 8MDF5V39QO 33X04XA5AT

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prismasol b22gk4/0 (source: ndc)
Generic Name magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride (source: ndc)
Application Number NDA021703 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 g/L
  • 5.4 g/L
  • 3.05 g/L
  • .314 g/L
  • 2.21 g/L
  • 7.07 g/L
source: ndc
Packaging
  • 2 BAG in 1 CASE (24571-111-06) / 5 L in 1 BAG
source: ndc

Packages (1)

24571-111-06 2 BAG in 1 CASE (24571-111-06) / 5 L in 1 BAG

Ingredients (6)

anhydrous dextrose (20 g/L) lactic acid (5.4 g/L) magnesium chloride (3.05 g/L) potassium chloride (.314 g/L) sodium bicarbonate (2.21 g/L) sodium chloride (7.07 g/L)

Linked Drug Pages (1)

PRISMASOL BGK2/0, PRISMASOL BGK2/3.5, PRISMASOL BGK4/2.5, PRISMASOL BGK0/2.5, PRISMASOL B22GK4/0, PRISMASOL BK0/0/1.2, PRISMASOL BGK4/0/1.2, PHOXILLUM BK4/2.5, PHOXILLUM B22K4/0 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "37da3e2a-3a1a-1784-e063-6394a90a969f", "openfda": {"unii": ["M4I0D6VV5M", "GR686LBA74", "660YQ98I10", "451W47IQ8X", "5SL0G7R0OK", "02F3473H9O", "8MDF5V39QO", "33X04XA5AT"], "spl_set_id": ["7f675fee-8940-4ece-bb0c-75ac79d8708c"], "manufacturer_name": ["Vantive US Healthcare LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BAG in 1 CASE (24571-111-06)  / 5 L in 1 BAG", "package_ndc": "24571-111-06", "marketing_start_date": "20081010"}], "brand_name": "PRISMASOL B22GK4/0", "product_id": "24571-111_37da3e2a-3a1a-1784-e063-6394a90a969f", "dosage_form": "INJECTION", "pharm_class": ["Acidifying Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "24571-111", "generic_name": "magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride", "labeler_name": "Vantive US Healthcare LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PRISMASOL", "brand_name_suffix": "B22GK4/0", "active_ingredients": [{"name": "ANHYDROUS DEXTROSE", "strength": "20 g/L"}, {"name": "LACTIC ACID", "strength": "5.4 g/L"}, {"name": "MAGNESIUM CHLORIDE", "strength": "3.05 g/L"}, {"name": "POTASSIUM CHLORIDE", "strength": ".314 g/L"}, {"name": "SODIUM BICARBONATE", "strength": "2.21 g/L"}, {"name": "SODIUM CHLORIDE", "strength": "7.07 g/L"}], "application_number": "NDA021703", "marketing_category": "NDA", "marketing_start_date": "20061025", "listing_expiration_date": "20261231"}